Literature DB >> 18543010

Health technology assessment: for whom the bell tolls?

Livio Garattini, Gianluigi Casadei.   

Abstract

Mesh:

Year:  2008        PMID: 18543010     DOI: 10.1007/s10198-008-0113-6

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


× No keyword cloud information.
  7 in total

1.  Pharmaceutical Price Schemes in Europe: Time for a 'Continental' One?

Authors:  Livio Garattini; Alessandro Curto; Nick Freemantle
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

2.  To model or not to model: lessons from two vaccinations.

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2011-06

3.  HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2020-02

4.  Pharmaceutical pricing conundrum: time to get rid of it?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-11

5.  Competition in pharmaceuticals: more product- than price-oriented?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-01

6.  Patient empowerment in Europe: is no further research needed?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-06

Review 7.  Assessing transferability in systematic reviews of health economic evaluations - a review of methodological guidance.

Authors:  Alina Weise; Roland Brian Büchter; Dawid Pieper; Tim Mathes
Journal:  BMC Med Res Methodol       Date:  2022-02-20       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.